This does not necessarily preclude effective Smac mimetic-based treatment of tumors composed of such cells though, as Smac mimetics can boost systemic TNFα levels, conceivably providing sufficient TNFα at the tumor site to enable Smac mimetics to activate cell death pathways. This evidence concerns the gene TNF and neoplasm.